GENE ONLINE|News &
Opinion
Blog

2026-05-06|

University of Nottingham Engineers Adaptable Nanoscale Platform for RNA Delivery

by GOAI
Share To

**New Drug Delivery Platform Shows Promise for Genetic Medicines**

Researchers have engineered an adaptable materials platform designed for the safe and efficient delivery of various genetic medicines. The innovation has the potential to expedite the creation of next-generation vaccines, cancer therapies, and gene-silencing medications.

The University of Nottingham’s School of Pharmacy developed the new drug delivery platform. The platform employs modular building blocks that self-assemble with Ribonucleic acid (RNA), resulting in the formation of nanoscale delivery particles.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 27, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10
India’s Pharmaceutical Growth Slows: Industry Needs New Strategies
2026-05-10
MoonLake Immunotherapeutics Concludes Pre-BLA Meeting with FDA and Reports Q1 2026 Financial Results
2026-05-10
New Method Allows Repeated Genetic Data Extraction From Living Cells Without Destruction
2026-05-10
Scroll to Top